FAMI
DGX icon

Fideuram Asset Management (Ireland)’s Quest Diagnostics DGX Stock Holding History

Fideuram Asset Management (Ireland)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41M Buy
+27,921
New +$5.48M 0.1% 269
2026
Q1 		– Sell
-96
Closed -$14.8K – 523
2025
Q4 		$14.8K Buy
+96
New +$17.5K ﹤0.01% 497

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Fideuram Asset Management (Ireland)'s DGX Position: Q2 2026 in Review

Fideuram Asset Management (Ireland) opened a new position in Quest Diagnostics (DGX) in Q2 2026: 27,921 shares worth $5.41M. The stake represents 0.1% of the portfolio and ranks #269 among its holdings. This is a return to the name: Fideuram Asset Management (Ireland) previously reported a position in DGX as recently as Q4 2025.

Fideuram Asset Management (Ireland) first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Fideuram Asset Management (Ireland) held 27,921 shares of Quest Diagnostics worth $5.41M as of Q2 2026.
  • Quest Diagnostics was a new Fideuram Asset Management (Ireland) position in Q2 2026.
  • Quest Diagnostics made up 0.1% of Fideuram Asset Management (Ireland)'s portfolio in Q2 2026, its #269 holding.
  • Fideuram Asset Management (Ireland) first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
  • 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Fideuram Asset Management (Ireland)'s 13F filing for Q2 2026, filed 23 Jul 2026.